• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
DTIL

DTIL

Precision BioSciences, Inc.

NASDAQHealthcareBiotechnologyUS

USD6.04

-0.28 (-4.43%)

Rating:C

Company Profile

CEO

Juli Blanche

IPO Date

2019-03-28

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$6.17

Prev. Close

$6.32

Day Low

$6.00

Day High

$6.35

52W Low

$3.53

52W High

$8.82

Market Cap

$0.08B

Volume

0.23M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

58.1%

Avg Negative

1.4%

Avg Neutral

40.4%

News Feed

Precision BioSciences: The Right Profile To Progress

Seeking Alpha·8/27/2021·↑ positive

Precision BioSciences (DTIL) May Report Negative Earnings: Know the Trend Ahead of Q2 Release

Zacks Investment Research·8/5/2021·↑ positive

Precision BioSciences Starts Dosing In Blood Cancer Trial With CAR T Therapy

Benzinga·7/1/2021·↑ positive

Precision BioSciences Doses First Patient in Phase 1 Allogeneic CAR T Clinical Trial of PBCAR19B Immune Evading Stealth Cell for Relapsed/Refractory Non-Hodgkin Lymphoma

Business Wire·7/1/2021·↑ positive

Precision BioSciences (DTIL) Surges 6.6%: Is This an Indication of Further Gains?

Zacks Investment Research·6/29/2021·↑ positive

DTIL Stock Price Increased Over 6%: Why It Happened

Pulse2·6/28/2021·↑ positive

Precision BioSciences Moves Higher After Commencing Dosing In PBCAR269A Combination Arm Of Multiple Myeloma Trial

Benzinga·6/28/2021·↑ positive

Precision BioSciences Reports Progress on Two Strategies Designed to Optimize Durability of Allogeneic CAR T Therapy in R/R Non-Hodgkin Lymphoma

Business Wire·6/4/2021·↑ positive

Precision BioSciences' CD-19 CAR T Therapy Shows Response Rate Of 77% In Lymphoma Trial

Benzinga·5/20/2021·↑ positive

DTIL Stock: Over 10% Increase Intraday Explanation

Pulse2·5/11/2021·↑ positive